Cited by 385Barrier Structure and Function StudiesMultiple Sclerosis Research StudiesDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Role of the Blood–Brain Barrier in Multiple Sclerosis

Ortiz, Genaro Gabriel, Pacheco-Moisés, Fermín Paul, Macías-Islas, Miguel Ángel, Flores-Alvarado, Luis Javier, Mireles-Ramírez, Mario A., González-Renovato, Erika Daniela, Hernández-Navarro, Vanessa Elizabeth, Sánchez-López, Angélica Lizeth, Alatorre-Jiménez, Moisés Alejandro·2014·Archives of Medical Research

DOI 10.1016/j.arcmed.2014.11.013

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system associated with demyelination and axonal loss eventually leading to neurodegeneration. MS exhibits many of the hallmarks of an inflammatory autoimmune disorder including breakdown of the blood-brain barrier (BBB). The BBB is a complex organization of cerebral endothelial cells, pericytes and their basal lamina, which are surrounded and supported by astrocytes and perivascular macrophages. In pathological conditions, lymphocytes activated in the periphery infiltrate the central nervous system to trigger a local immune response that ultimately damages myelin and axons. Cytotoxic factors including pro-inflammatory cytokines, proteases, and reactive oxygen and nitrogen species accumulate and may contribute to myelin destruction. Dysregulation of the BBB and transendothelial migration of activated leukocytes are among the earliest cerebrovascular abnormalities seen in MS brains and parallel the release of inflammatory cytokines. In this review we establish the importance of the role of the BBB in MS. Improvements in our understanding of molecular mechanism of BBB functioning in physiological and pathological conditions could lead to improvement in the quality of life of MS patients.

Integrity signals

Registry

Crossref · 10.1016/j.arcmed.2014.11.013

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,100
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3265 · Cited by 1,029
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. J., & Mills, K. H. G. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 975
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Griendling, K. K., Sorescu, D., Lassegue, B. P., & Ushio‐Fukai, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Nitric Oxide Production and Signaling in Inflammation
Korhonen, R., Lahti, A., Kankaanranta, H., & Moilanen, E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010054526359 · Cited by 920
Nitric oxide and redox mechanisms in the immune response
Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1010550 · Cited by 765
Free Radical Pathways in CNS Injury
LEWÉN, A., MATZ, P., & CHAN, P. H. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.871 · Cited by 759

Flagged first, then by citations

Show all 88 references

Research works printed but not linked: 1

Loch-Neckel, 2010, The blood-brain barrier and the drug delivery in the central nervous system, Rev Neurol, 51, 165

Sorted by citations

Items 201–300 of 385

Melatonin Protects Against Cocaine‐Induced Blood−Brain Barrier Dysfunction and Cognitive Impairment by Regulating miR‐320a‐Dependent GLUT1 Expression
Wei, J., Liu, H., Li, Y., Zhao, D., Wang, B., Wang, H., Wang, L., Wang, K., Yue, J., Zhang, H., et al. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70002 · Cited by 10
Interleukin-2 and its receptors: Implications and therapeutic prospects in immune-mediated disorders of central nervous system
Zhang, Y., Kong, Q., Fan, J., & Zhao, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107658 · Cited by 14
The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E., Alruwaili, M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70067 · Cited by 11
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms
Coclitu, C., Constantinescu, C. S., & Tănăsescu, R. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2510405 · Cited by 12
Compensatory Neuroprotective Response of Thioredoxin Reductase against Oxidative-Nitrosative Stress Induced by Experimental Autoimmune Encephalomyelitis in Rats: Modulation by Theta Burst Stimulation
Stevanović, I. D., Ninković, M., Mancic, B., Milivojevic, M., Stojanović, I. R., Ilic, T. V., Vujović, M., & Djukic, M. M. (2020) · Molecules · doi:10.3390/molecules25173922 · Cited by 12
Emerging deep learning techniques using magnetic resonance imaging data applied in multiple sclerosis and clinical isolated syndrome patients (Review)
Kontopodis, E., Papadaki, E. Z., Trivzakis, E., Maris, T. G., Simos, P. G., Papadakis, G. Z., Tsatsakis, A. M., Spandidos, D. A., Karantanas, A. H., & Kostas Marias, A. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10583 · Cited by 11
A least-squares-fitting procedure for an efficient preclinical ranking of passive transport across the blood–brain barrier endothelium
Jorgensen, C., Troendle, E. P., Ulmschneider, J. P., Searson, P. C., & Ulmschneider, M. B. (2023) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-023-00525-1 · Cited by 11
Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
Ruggieri, M., Gargano, C. D., Ferretta, A., Manni, A., Capacchione, A., Frigeri, A., Iaffaldano, P., Trojano, M., & Paolicelli, D. (2020) · Brain Sciences · doi:10.3390/brainsci10080548 · Cited by 11
Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation
Young, T. L., Zychowski, K. E., Denson, J. L., & Campen, M. J. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.010 · Cited by 11
The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication
Li, F., Luo, Q., Guo, T., Zhou, S., Cheng, Z., Pan, H., & Tu, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561789 · Cited by 12
Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Pearse, D. D., Otero, P. A., Diaz, A., Pan, X., & Ghosh, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.034 · Cited by 10
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation
Chiarelli, A. M., Villani, A., Mascali, D., Petsas, N., Biondetti, E., Caporale, A. S., Digiovanni, A., Grasso, E. A., Ajdinaj, P., D’Apolito, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19113-8 · Cited by 10
Comparing RNA ‐sequencing datasets from astrocytes, oligodendrocytes, and microglia in multiple sclerosis identifies novel dysregulated genes relevant to inflammation and myelination
Drake, S., Zaman, A., Simas, T., & Fournier, A. E. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1594 · Cited by 12
Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder
Chang, B., Ro, L., Chen, C., Lo, Y., Lyu, R., Kuo, H., Liao, M., Chang, C., Chang, H., Huang, C., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51167 · Cited by 12
High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica
Zhang, Q., Pei, S., Chen, J., Peng, Y., Zhou, Z., Wang, Z., & Wang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705536 · Cited by 11
Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia
Geronikolou, S. A., Takan, I., Pavlopoulou, A., Mantzourani, M., & Chrousos, G. P. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5090 · Cited by 10
Systemic Infection by Non-albicans Candida Species Affects the Development of a Murine Model of Multiple Sclerosis
Fraga‐Silva, T. F. D. C., Munhoz-Alves, N., Mimura, L. A. N., de Oliveira, L. R. C., Figueiredo-Godoi, L. M. A., Garcia, M. T., Oliveira, E. S., Ishikawa, L. L. W., Zorzella-Pezavento, S. F. G., Bonato, V. L. D., et al. (2022) · Journal of Fungi · doi:10.3390/jof8040386 · Cited by 10
Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis
Mehdi-Alamdarlou, S., Ahmadi, F., Shahbazi, M., Azadi, A., & Ashrafi, H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08322-7 · Cited by 10
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis
D’Aversa, E., Salvatori, F., Vaccarezza, M., Antonica, B., Grisafi, M., Singh, A. V., Secchiero, P., Zauli, G., Tisato, V., & Gemmati, D. (2024) · Cells · doi:10.3390/cells13161316 · Cited by 10
Non-saponin from Panax ginseng maintains blood-brain barrier integrity by inhibiting NF-κB and p38 MAP kinase signaling pathways to prevent the progression of experimental autoimmune encephalomyelitis
Oh, J., Ha, Y., Kwon, T. W., Jo, H.-S., Moon, S., Lee, Y., Nah, S.-Y., Kim, M. S., & Cho, I. (2024) · Journal of Ginseng Research · doi:10.1016/j.jgr.2024.09.005 · Cited by 9
Evaluation of the glymphatic system in relapsing remitting multiple sclerosis by measuring the diffusion along the perivascular space
Csomós, M., Veréb, D., Kocsis, K., Faragó, P., Tóth, E. M., Antal, S. I., Bozsik, B., Tuka, B., Király, A., Szabó, N., et al. (2025) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2025.110319 · Cited by 10
Neuromodulatory role and therapeutic potential of N6-methyladenosine RNA methylation in neurodegenerative diseases
Zhang, J., Ma, W., Liu, R., Li, X., Yuan, Z., & Cheng, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01648 · Cited by 11
Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS
Sun, X., Zhang, F., Wang, L., Lee, G., Yang, S., Zhou, D., Chang, B., Hu, B., & Zhou, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604987 · Cited by 14
Impact of astrocyte and lymphocyte interactions on the blood-brain barrier in multiple sclerosis
Yan, X.-B., Zhao, Y.-F., Yang, Y., Wang, N., He, B.-Z., & Qiu, X. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.12.006 · Cited by 9
Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes
Swindell, W. R., Bojanowski, K., & Chaudhuri, R. K. (2022) · Pharmaceuticals · doi:10.3390/ph15040461 · Cited by 9
RETRACTED: Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
Haghmorad, D., Eslami, M., Rashidy‐Pour, A., Tarahomi, M., Tavaf, M. J., Soltanmohammadi, A., Zargarani, S., Goltappeh, B. Y., Kamyshnyi, O., & Oksenych, V. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110388 · Cited by 9
Retracted
Transcellular traversal of the blood‐brain barrier by the pathogenic Propionibacterium acnes
Lu, X., Xian-long, Q., Yi, X., Jian, Z., & Gao, T. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28132 · Cited by 9
Induction of Heme Oxygenase-1 by 15d-Prostaglandin J2 Mediated via a ROS-Dependent Sp1 and AP-1 Cascade Suppresses Lipopolysaccharide-Triggered Interleukin-6 Expression in Mouse Brain Microvascular Endothelial Cells
Yang, C.-C., Hsiao, L., Shih, Y.-F., Chang, C.-I., & Chang, C.-I. (2022) · Antioxidants · doi:10.3390/antiox11040719 · Cited by 9
Research progress of statins on immune regulation of multiple sclerosis and experimental allergic encephalomyelitis
Xu, D., & Wang, M. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i6.658 · Cited by 9
Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier
McCloskey, M. C., Kasap, P., Trempel, M., Widom, L. P., Kuebel, J., Chen, K., Gaborski, T. R., Engelhardt, B., & McGrath, J. L. (2024) · Journal of Visualized Experiments · doi:10.3791/65258 · Cited by 8
Role of T cell-induced autoimmune response in the pathogenesis of glaucoma
Liang, S. (2024) · International Ophthalmology · doi:10.1007/s10792-024-03224-4 · Cited by 8
Upregulation of C-X-C motif chemokine 12 in the spinal cord alleviated the symptoms of experimental autoimmune encephalomyelitis in Lewis rats
Lin, D., Liu, H., Song, H., Chen, B., Fu, J., Sun, M., Zhou, H., Bai, W., Wei, S., & Li, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1105530 · Cited by 8
Homocysteine and markers of endothelial dysfunction in multiple sclerosis
Спирина, Н. Н., Спирин, Н. Н., Kiseleva, E. V., Александровна, Д. Е., & Boyko, A. N. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112107290 · Cited by 8
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
Har-Shalom, I., Karni, A., & Kolb, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010474 · Cited by 9
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis
Hamdi, L., Nabat, H., Goldberg, Y., Fainstein, N., Segal, S., Mediouni, E., Asis, Y., Touloumi, O., Grigoriadis, N., Katz, A., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51677 · Cited by 8
Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes
Kumar, V., & Gupta, U. D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104466 · Cited by 8
The molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 8
Pericyte Dysfunction Contributes to Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
Lin, S., Landon, B., Zhang, H., & Jin, K. (2023) · Aging and Disease · doi:10.14336/ad.2023.0821-1 · Cited by 9
The impact of pericytes on the brain and approaches for their morphological analysis
Kolinko, Y., Králíčková, M., & Tonar, Z. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.003 · Cited by 8
Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles
Geiger, M. K., Hayter, E., Martin, R. S., & Spence, D. M. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100161 · Cited by 7
Microbiota-Immune System Interactions in Human Neurological Disorders
Huang, Q., Fang, Y., Liao, D., & Xia, J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200726222138 · Cited by 7
Protocadherin gamma C3: a new player in regulating vascular barrier function
Burek, M., Kaupp, V., Blecharz-Lang, K. G., Dilling, C., & Meybohm, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343896 · Cited by 7
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
Gozzo, L., Romano, G., Brancati, S. B., Longo, L., Vitale, D., & Drago, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1169400 · Cited by 5
Pericyte derivation and transplantation for blood-CNS barrier reconstitution in CNS disorders
Kim, H., Wu, K. L., Tam, K.-W., Chan, Y., & Shum, D. K. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.12.007 · Cited by 7
New curcumin-loaded nanocapsules as a therapeutic alternative in an amnesia model
Rodrigues, K. D. C., Neto, M. R. D. S., Barboza, V. D. S., Hass, S. E., Vaucher, R. D. A., Giongo, J. L., Schumacher, R. F., Wilhelm, E. A., & Luchese, C. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-023-01329-w · Cited by 8
Promises of Lipid-Based Nanocarriers for Delivery of Dimethyl Fumarate to Multiple Sclerosis Brain
Subhash, S., Chaurawal, N., & Raza, K. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_31 · Cited by 7
Gateway Reflex and Mechanotransduction
Matsuyama, S., Tanaka, Y., Hasebe, R., Hojyo, S., & Murakami, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.780451 · Cited by 9
Nanodelivery of antiretroviral drugs to nervous tissues
Lawal, S. K., Olojede, S. O., Faborode, O. S., Aladeyelu, O. S., Matshipi, M. N., Sulaiman, S. O., Naidu, E. C., Rennie, C. O., & Azu, O. O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025160 · Cited by 7
Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function
Bae, J., Li, C., Masurkar, A. V., Ge, Y., & Kim, S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120284 · Cited by 8
History of head trauma and the risk of multiple sclerosis: A systematic review and meta-analysis
Abouelmagd, M. E., AbdelMeseh, M., Hassan, A., Ali, M. A., Mohamed, R. G., Mady, A., Hindawi, M. D., & Meshref, M. M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106183 · Cited by 7
Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesions
Silva, B. A., Farías, M. I., Miglietta, E. A., Leal, M. C., Ávalos, J. C., Pitossi, F. J., & Ferrari, C. C. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103346 · Cited by 6
Resistance training modifies of serum levels of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases in multiple sclerosis women - a randomized controlled trail
Nezhad, N. N., Parnow, A., Khamoushian, K., Eslami, R., & Baker, J. S. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00856-1 · Cited by 6
Vascular endotelial dysfunction is a pathogenetic factor in the development of neurodegenerative diseases and cognitive impairment
Goncharov, N. V., Popova, P. I., Головкин, А. С., Zalutskaya, N. M., Palchikova, E. I., Zanin, K., & Avdonin, Р. V. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-3-11-26 · Cited by 7
Glycolipids in Parkinson's disease: beyond neuronal function
Spanos, F., & Deleidi, M. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13651 · Cited by 6
Recent Advances in Nanoparticle-Based Antiretroviral Drug Delivery Systems for HIV Treatment and Prevention: A Comprehensive Review
Das, G., Shin, H., & Patra, J. K. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s540578 · Cited by 6
Track‐Etched Membranes for Drug Pharmaceutical Research
Cuanalo-Contreras, K., Hogrebe, A. M. R., Teichmann, K., & Benkmann, D. (2023) · Chemie Ingenieur Technik · doi:10.1002/cite.202300089 · Cited by 5
Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model
Hao, Y., Su, Y., He, Y., Zhang, W., Liu, Y., Guo, Y., Chen, X., Liu, C., Han, S., Wang, B., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03005-3 · Cited by 7
A new model for chronic diseases
Diani, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.02.011 · Cited by 5
Advances in human brain proteomics analysis of neurodegenerative diseases
Chen, Y., Wang, X., & Xu, B. (2022) · Human Brain · doi:10.37819/hb.001.001.0197 · Cited by 5
Blood–brain barrier: A novel therapeutic target in multiple sclerosis
Kuwahara, H., Nishina, K., & Yokota, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12212 · Cited by 5
Effect of fingolimod on white blood cell, lymphocyte and neutrophil counts in MS patients.
Zadeh, A. R., Parsa, S., Tavoosi, N., Farshi, M., & Masaeli, M. F. (2019) · Europe PMC (PubMed Central) · Cited by 6
Retracted
Nanoparticle-based strategies for overcoming the blood-brain barrier in CNS disorders and brain cancer: precision diagnostics and therapeutics for Alzheimer’s, Parkinson’s, multiple sclerosis, and glioblastoma
Feyzbakhsh, H. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2599564 · Cited by 5
Challenges and opportunities in neurodegenerative diseases management
Syed, J. M., Nemichandra, S. C., Sridhar, S. B., Shareef, J., Ramesh, M., & Chalasani, S. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00026-x · Cited by 4
Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder
Yuan, C., Liu, X., Cai, S., Zhang, L., Guo, R., Jia, Z., Sun, Y., & Li, B. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104504 · Cited by 4
Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature
Wakid, M., Almeida, D. M., Aouabed, Z., Rahimian, R., Davoli, M. A., Yerko, V., Leonova-Erko, E., Richard, V. R., Zahedi, R. P., Borchers, C. H., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100684 · Cited by 4
Identification of Key Genes and Regulatory Pathways in Multiple Sclerosis Brain Samples: A Meta-Analysis of Micro-Array Datasets
Jansen, M. I., & Castorina, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119361 · Cited by 5
Advances and challenges toward neural regenerative medicine
Dehghani, P., Jahed, V., & Zarrabi, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00001-2 · Cited by 4
Regulation of the Blood–Brain Barrier in Health and DiseasePreprint
Rada, C. C., Yuki, K., Ding, J., & Kuo, C. J. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041191 · Cited by 4
Increased blood–brain barrier leakage in schizophrenia spectrum disorders compared to healthy controls in dynamic contrast-enhanced magnetic resonance imagingPreprint
Moussiopoulou, J., Yakimov, V., Rauchmann, B., Toth, H., Melcher, J., Jäger, I. M., Lutz, I., Kallweit, M. S., Papazov, B., Seelos, K., et al. (2023) · medRxiv · doi:10.1101/2023.12.12.23299782 · Cited by 4
Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization
Chen, X., Zhang, J., & Mu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199297 · Cited by 3
Multiple sclerosis updates and the safety and efficacy of Bruton tyrosine kinase inhibitors in it: A systematic review
Prajjwal, P., Patel, P. V., Patel, Z. V., Inban, P., Patel, D., Mahato, P., Shamim, L., Godinho, N. J. S., & Tekuru, Y. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102012 · Cited by 3
Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis
Weatherley, G. R., Araujo, R. P., Dando, S. J., & Jenner, A. L. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013273 · Cited by 3
CAR T-Cell Immunotherapy in Neuroautoimmune Diseases: Focus on the Central Nervous System
Demetriou, F., & Anagnostouli, M. C. (2026) · Biomedicines · doi:10.3390/biomedicines14020296 · Cited by 3
Spatial transcriptomic profiling uncovers the molecular effects of the neurotoxicant polychlorinated biphenyls (PCBs) in the brains of adult mice
Basu, B., Breese, N. M., Lombardi, S., Wang, H. M., Li, X., Tiburcio, D., Niemasz, Z., Beyer, S. E., Dean, L. E., Marek, R. F., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03466-x · Cited by 3
A2AR antagonist treatment for multiple sclerosis: Current progress and future prospects
Qi, C.-X., Feng, Y., Jiang, Y., Chen, W., Vakal, S., Chen, J., & Zheng, W. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.012 · Cited by 3
The effects of different types of smoking on recovery from attack in hospitalized multiple sclerosis patients
Hosseini, M., Haghighatzadeh, M., Hassanpour, R., Asadollahzadeh, E., Rezaeimanesh, N., Eskandarieh, S., Navardi, S., Ghadiri, F., Moghadasi, A. N., & Sahraian, M. A. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107846 · Cited by 3
Employing metabolomic approaches to determine the influence of age on experimental autoimmune encephalomyelitis (EAE)
Lee, S. H., Lee, G., Seo, J., Hasan, M., Kwon, O., & Jung, B. H. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.04.008 · Cited by 3
The blood brain barrier
Werner, C., Mathkour, M., & Tubbs, R. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819509-3.00014-6 · Cited by 3
High-fat diet-induced cellular neuroinflammation: Alteration of brain functions and associated aliments
Umare, M. D., Bajaj, K. K., Wankhede, N. L., Taksande, B. G., Upaganlawar, A., Umekar, M. J., & Kale, M. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89834-8.00031-3 · Cited by 3
[New neuroimaging methods in assessing the activity of neuroinflammation in multiple sclerosis].
Boyko, A. N., Dolgushin, M., & Karalkina, M. A. (2023) · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · doi:10.17116/jnevro20231230728 · Cited by 2
Multiple Sclerosis. Some Features of Pathology and Prospects for Therapy. Part 1
Константиновна, Ф. Е., Vorobjeva, N. V., & Muntyan, M. S. (2024) · Advances in Gerontology · doi:10.1134/s2079057024600630 · Cited by 3
Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?
Ortíz, G. G., Mireles-Ramírez, M. A., Pacheco-Moisés, F. P., Ramírez-Jirano, L. J., Bitzer-Quintero, O. K., Delgado-Lara, D. L. C., Flores-Alvarado, L. J., Mora-Navarro, M. A., Huerta, M., & Torres-Mendoza, B. M. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1786087 · Cited by 3
Self-citation
Evaluation of the Prevalence of Anti-transglutaminase 2 and 6 Antibodies in Patients with Sero-Positive Multiple Sclerosis
Emami, M. H., Najafi, M. R., Allahdadian, S., Mohammadzadeh, S., Jamali, N., Lalazaryan, A., Nejad, V. S., & Maghool, F. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.368 · Cited by 2
Material considerations for delivering therapeutics across the blood–brain barrier
Zoba, A. N., & Tringides, C. M. (2025) · APL Materials · doi:10.1063/5.0284305 · Cited by 2
Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis
Kontaxis, S., Laporta, E., Pagès, E. G., Guerrero, A. I., Zabalza, A., Martinis, M., Lucia, R., Simblett, S. K., Weyer, J., Hotopf, M. H., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1145818 · Cited by 2
Endothelial Microsomal Prostaglandin E Synthetase-1 Upregulates Vascularity and Endothelial Interleukin-1β in Deteriorative Progression of Experimental Autoimmune Encephalomyelitis
Takemiya, T., Kawakami, M., & Takeuchi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113647 · Cited by 2
Introduction: Nanomedicine in the Brain
Li, T., Huang, L., & Xue, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_1 · Cited by 2
Scorpion Toxins from Buthus martensii Karsch (BmK) as Potential Therapeutic Agents for Neurological Disorders: State of the Art and Beyond
Wang, X., Zhang, S., Zhu, Y., Zhang, Z., Sun, M., Cheng, J., Xiao, Q., Li, G., & Tao, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90889 · Cited by 2
Molecular therapeutic strategies in neurodegenerative diseases and injury
Tora, M. S., Texakalidis, P., Greven, A., Faraj, R. R., Gendreau, J. L., Liang, Z., Federici, T., & Boulis, N. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00012-x · Cited by 2
The Blook-Brain Barrier in Health and Disease
Mayhan, W. G., & Arrick, D. M. (2016) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00148ed1v01y201612isp072 · Cited by 2
CNS Demyelination Diseases Following Exposure to Urban Air Pollution
Ehsanifar, M. (2022) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1423 · Cited by 2
Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
Iyer, S., Verma, S., Marathe, S. A., & Tare, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_11 · Cited by 2
Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literature
Dutta, R. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001035 · Cited by 3
Modulation of monocyte responses by progressive multiple sclerosis therapy.
Beyers, C. Z. (2020) · doi:10.26686/wgtn.17148233.v1 · Cited by 2
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculaturePreprint
Kemble, A. M., Hornsperger, B., Ruf, I., Richter, H. G., Benz, J., Kuhn, B., Heer, D., Wittwer, M., Engelhardt, B., Grether, U., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.490688 · Cited by 2
A quantitative measure of choroid plexus contrast enhancement strongly relates to markers of diffuse brain tissue injury in multiple sclerosisPreprint
Senthil, S., Tagge, I., Fetco, D., Hsieh, C. H., Assemlal, H.-E., Karimaghaloo, Z., Fetco, E., Moore, G. R. W., Arnold, D. L., Rudko, D. A., et al. (2025) · medRxiv · doi:10.1101/2025.03.26.25324694 · Cited by 2
Efficiency of Nanoparticles (Micromage-B) in the Complex Treatment of Multiple Sclerosis
Belousov, A. (2023) · Clinical Research and Clinical Reports · doi:10.31579/2835-8325/010 · Cited by 1
Рассеянный склероз. Некоторые особенности патологии и возможные пути терапии. Часть 1
Константиновна, Ф. Е., Vorobjeva, N. V., & Muntyan, M. S. (2024) · Vestnik Moskovskogo universiteta Seria 16 Biologia · doi:10.55959/msu0137-0952-16-79-2-2 · Cited by 1
mRNA expression profile from whole blood revealed a cluster of 25 shared differentially expressed genes inversely related in multiple sclerosis and inflammatory bowel disease
Palanivel, V., Tiwari, P., Kaur, A., & Senapati, S. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106301 · Cited by 1
miR-142 regulates the function of microvascular endothelial cells through MAT2B
Liu, C.-Y., Chen, D.-C., Zhang, Z.-H., Li, T., & Ji, L.-L. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110501 · Cited by 2

Authors: Ortiz, G. G., Pacheco-Moisés, F. P., Macías-Islas, M. Á., Flores-Alvarado, L. J., Mireles-Ramírez, M. A., González-Renovato, E. D., Hernández-Navarro, V. E., Sánchez-López, A. L., & Alatorre-Jiménez, M. A.
Affiliations: Mexican Social Security Institute (MX)
Universidad de Guadalajara (MX)
ORCID: Macías-Islas, Miguel Ángel
Flores-Alvarado, Luis Javier
Mireles-Ramírez, Mario A.
Sánchez-López, Angélica Lizeth
Alatorre-Jiménez, Moisés Alejandro
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2014-11
Volume: 45
Issue: 8
Pages: 687-697
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/j.arcmed.2014.11.013
OpenAlex: W2001448765
Cited by: 373
References: 88
Citations by year: 2026: 20 · 2025: 32 · 2024: 56 · 2023: 54 · 2022: 48 · 2021: 40 · 2020: 46 · 2019: 16 · 2018: 29 · 2017: 12 · 2016: 9 · 2015: 11
FWCI: 0.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: multiple sclerosis, blood-brain barrier, demyelination, neuroinflammation, leukocyte transendothelial migration, brain endothelial cells, pericytes, astrocytes, perivascular macrophages, inflammatory cytokines, reactive oxygen and nitrogen species, myelin destruction, axonal loss, neurodegeneration
MeSH terms: Astrocytes, Blood-Brain Barrier, Cell Adhesion, Humans, Inflammation, Lymphocytes, Macrophages, Multiple Sclerosis, Cell Adhesion Molecules, Cytokines, Oxidative Stress, Endothelial Cells, Transendothelial and Transepithelial Migration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of the Blood–Brain Barrier in Multiple Sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks